- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06462937
A Digital Exercise Intervention in Patients With Spondyloarthritis (SPARK)
The SPARK Trial: a Digital Exercise Intervention in Patients With Spondyloarthritis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Main objectives: To assess if a digital personally tailored exercise program with remote follow-up can reduce disease activity measured by ankylosing spondylitis disease activity score (ASDAS) in patients with recently diagnosed axial spondyloarthritis (axSpA).
Main inclusion criteria Adults (> 18 years) with clinical diagnosis from a rheumatologist of axSpA within the last 2 years of inclusion also fulfilling the ankylosing spondylitis disease activity score (ASAS) classification criteria, who are biologic disease modifying anti-rheumatic drugs (bDMARD) naïve, and have an active disease (ASDAS ≥ 1.3)
Main exclusion criteria:
Active iridocyclitis, c-reactive protein (CRP) > 30, contraindication to high intensity interval training
Primary outcome Proportion of participants in ASDAS inactive (ASDAS < 1.3) at 3 months
Number of participants: 260 (with an anticipated drop-out rate of 15%)
Study design: A two-arm multi-centre, clinical trial, randomization 1:1 to either digital exercise intervention with remote follow-up or usual care.
Intervention: Exercise delivered through an application and with personalised follow-up by a coach through remote sessions (the participant and SPARK-coach are not at the same physical location) weekly. The exercise is progressively tailored to the fitness level of each participant. The program consists of 5 session per week on 3 different days including: two sessions with HIIT, 2 sessions with strength exercise, and one session with an aerobic exercise at moderate intensity. Goal for HIIT is 10 minutes two times per week at 85-95% of maximal heart rate (20 minutes in total). The exercise will be performed at a location of the participants' choice and data will be logged by a sports watch.
Efficacy assessments: ASDAS disease activity measure (4 patient reported questions and measure of CRP), Bath ankylosing spondylitis disease activity index (BASDAI).
Physical measure: cardiorespiratory fitness, in a subset of participants direct cardiopulmonary testing, muscular strength tests.
Psychological measures: Warwick and Edinburgh mental wellbeing scale (WEMWBS), EuroQol (EQ5D).
Medication: use of bDMARDs, use of NSAID
Safety assessments General physical examination and vital signs, laboratory tests as a part of usual clinical care, record of adverse events and serious adverse events, magnetic resonance imaging (MRI).
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Sella A Provan, Professor
- Phone Number: +4791582581
- Email: SellaProvan@gmail.com
Study Contact Backup
- Name: Birgitte Nellemann, PhD
- Phone Number: +4747957020
- Email: birgittenellemann@gmail.com
Study Locations
-
-
-
Oslo, Norway
- Diakonhjemmet hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- axSpA diagnosis within the last two years by a rheumatologist according to the ASAS criteria of 2009
- active disease (ASDAS > 1.3)
Exclusion Criteria:
- Active uveitis.
- CRP > 30.
- Former or current use of bDMARDs.
- Pregnancy or planned pregnancy within 6 months from inclusion.
- Absolute and relative contradictions to high intensity exercise according to the American College of Sports Medicine (ACSM)
- Other serious disease such as cancer.
- Patients incapable to follow the protocol or the control set-up with remote monitoring.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Exercise with personal supervision 0-3 months
Exercise
|
Remote exercise will be administered with digital supervision.
The Exercise group will receive a personalised program with individual adaptations aiming to perform 3 exercise sessions per week including HIIT, strength exercise and moderate intensive aerobic exercise.
Participants will consult their rheumatologist parallel to the SPARK trial.
|
No Intervention: Control 0-3 months
Usual care
|
|
Experimental: Exercise with personal supervision 3-6 months
Exercise
|
Remote exercise will be administered with digital supervision.
The Exercise group will receive a personalised program with individual adaptations aiming to perform 3 exercise sessions per week including HIIT, strength exercise and moderate intensive aerobic exercise.
Participants will consult their rheumatologist parallel to the SPARK trial.
|
Active Comparator: Exercise without personal supervision 3-6 months
Exercise
|
Remote exercise will be administered without digital supervision.
Participants will receive a standard exercise program fulfilling the exercise protocol requirements, the exercise program will progress.
But there will be no direct contact between the participant and the coach.
Participants will consult their rheumatologist parallel to the SPARK trial.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Disease activity 3 months
Time Frame: 3 months
|
Number of participants in ASDAS inactive (ASDAS < 1.3) at 3 months
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Biologic disease modifying anti-rheumatic drugs 3 months
Time Frame: 3 months
|
Number of participants on biologic disease modifying anti-rheumatic drugs (bDMARD) at 3 months
|
3 months
|
Disease activity 6 months
Time Frame: 6 months
|
Number of participants in ankylosing spondylitis disease activity score (ASDAS) inactive (ASDAS < 1.3) at 6 months
|
6 months
|
Proportion of participants using non-steroidal anti-inflammatory drugs
Time Frame: 3 and 6 months
|
Usage of non-steroidal anti-inflammatory drugs (NSAIDs)
|
3 and 6 months
|
Bath ankylosing spondylitis metrology index
Time Frame: 3 and 6 months
|
Physical function measured by Bath ankylosing spondylitis metrology index (BASMI).
Range 0-10 where 0= no functional impairment 10=very significant impairment
|
3 and 6 months
|
Bath ankylosing spondylitis function index
Time Frame: 3 and 6 months
|
Physical function measured by Bath ankylosing spondylitis function index (BASFI).
Scale range 0-10, where 0= no functional impairment 10=very significant impairment
|
3 and 6 months
|
Ankylosing spondylitis Performance Index
Time Frame: 3 and 6 months
|
Physical function measured by Ankylosing spondylitis Performance Index (ASPI).
Continuous variable in units of minutes.
The functional level is inversely proportional to the number of minutes.
|
3 and 6 months
|
Physical fitness
Time Frame: 3 and 6 months
|
Indirect exercise test on a tread-mill until exhaustion.
Measured in oxygen uptake ml/min/kg.
|
3 and 6 months
|
Physiological effects of exercise on lipids
Time Frame: 3 and 6 months
|
Effect of exercise on lipids
|
3 and 6 months
|
Physiological effects of exercise on inflammation measured by CRP
Time Frame: 3 and 6 months
|
Effect of exercise on CRP
|
3 and 6 months
|
Physiological effects of exercise on blood pressure
Time Frame: 3 and 6 months
|
Effect of exercise on blood pressure
|
3 and 6 months
|
Physiological effects of exercise on weight
Time Frame: 3 and 6 months
|
Effect of exercise on weight in kg
|
3 and 6 months
|
Physiological effects of exercise on muscle mass
Time Frame: 3 and 6 months
|
Effect of exercise on body composition measured as percentage muscle mass
|
3 and 6 months
|
Physiological effects of exercise on adipose tissue
Time Frame: 3 and 6 months
|
Effect of exercise on body composition measured as percentage adipose tissue
|
3 and 6 months
|
Safety measures of exercise Spine
Time Frame: 3 and 6 months
|
Safety measures: MRI spine in a subset of participants at baseline and after 3 months of exercise.
Level of inflammation scored by Canadian Spondyloarthritis Research Consortium score (SPARCC).
High score represents more inflammation.
The minimum score 0, max score 108
|
3 and 6 months
|
Safety measures of exercise Sacroiliac joints
Time Frame: 3 and 6 months
|
Safety measures: MRI sacroiliac joints in a subset of participants at baseline and after 3 months of exercise.
Level of inflammation scored by Canadian Spondyloarthritis Research Consortium (SPARCC).
High score represents more inflammation.
The minimum score 0, max score 72
|
3 and 6 months
|
Effects of exercise on mental wellbeing
Time Frame: 3 and 6 months
|
Quality of life Warwick Edinburgh Mental Wellbeing Scale WEMWBS).
Range 14-70.
A higher score indicates greater mental well-being
|
3 and 6 months
|
Effects of exercise on quality of life
Time Frame: 3 and 6 months
|
Quality of life EQ5D.
Range -0.59 to 1, where 1 is the best possible health state
|
3 and 6 months
|
Work presenteeism
Time Frame: 6 months
|
Health economy measures: work presenteeism expressed in percentage (%) measured by Work Productivity and Activity Impairment Questionnaire (WPAI)
|
6 months
|
Work absenteeism
Time Frame: 6 months
|
Health economy measures: work absenteeism expressed in percentage (%) measured by Work Productivity and Activity Impairment Questionnaire (WPAI)
|
6 months
|
Work impairment
Time Frame: 6 months
|
Health economy measures: work overall impairment expressed in percentage (%) measured by Work Productivity and Activity Impairment Questionnaire (WPAI)
|
6 months
|
Functional impairment
Time Frame: 6 months
|
Health economy measures: functional impairment expressed in percentage (%) measured by Work Productivity and Activity Impairment Questionnaire (WPAI)
|
6 months
|
Contact with the Healthcare services
Time Frame: 6 months
|
Health economy measures: Contact with the health care services.
Self reported as number of visits to general practitioner, specialist healthcare and/or physiotherapist during past 3 months
|
6 months
|
Sleep quality
Time Frame: 3 and 6 months
|
Questionnaire on sleep quality: Pittsburgh Sleep Questionnaire.
Global score ranges from 0 to 21 and higher scores indicate poorer sleep quality.
|
3 and 6 months
|
Physical activity level
Time Frame: Baseline, 3 and 6 months
|
Physical activity level measured for one week at baseline, 3 months and 6 months by a movement sensor.
(Actigraph).
The score will be presented as Metabolic Equivalents.
A high score represents more movement
|
Baseline, 3 and 6 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DS00735
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Exercise
-
Faculdade de Motricidade HumanaCompletedGreen Exercise | Indoor ExercisePortugal
-
Istanbul Medipol University HospitalCompletedPulmonary Rehabilitation | Exercise Capacity | Exercise TestTurkey
-
University Hospital MuensterGerman Federal Ministry of Education and ResearchUnknownAerobic Exercise | Anaerobic Exercise | Unchanged ConditionGermany
-
Hasan Kalyoncu UniversityNot yet recruiting
-
University of HawaiiKlein Buendel, Inc.CompletedMomZing Exercise Videos Online | Standard Exercise DVDUnited States
-
Paracelsus Medical UniversityDepartment of Psychiatry University of BonnRecruitingHealthy | Exercise | Physical Fitness | Exercise TestAustria
-
Nathaniel JenkinsCompletedExercise Training | Physical Exertion | Desire to ExerciseUnited States
-
University of Alberta, Physical EducationCompletedSedentary Behaviour | Adherence | Traditional Exercise | Lifestyle ExerciseCanada
-
University of GeorgiaRecruitingBiomarkers | Aerobic Exercise | Acute ExerciseUnited States
-
University of TaipeiCompletedAerobic Exercise | Massage | Anaerobic Exercise
Clinical Trials on Exercise with supervision
-
University of PotsdamSwiss Council for Accident Prevention; Prof. Dr. Reto W. Kressig and Dr. Yves...CompletedFall Prevention | Fall Risk FactorsGermany
-
Meir Medical CenterTerminated
-
National Cheng-Kung University HospitalCompletedQuality of Life | Pulmonary Rehabilitation | COPD | COPD Exacerbation | Virtual Reality | Pulmonary Function | Muscle Strength | Readmission | Weight TrainingTaiwan
-
Centre Francois BaclesseUNICANCERNot yet recruitingBreast Cancer | Cognitive DysfunctionFrance
-
Botec Analysis, LLCPennsylvania Department of Corrections; Bureau of Justice AssistanceUnknownSubstance Abuse | Criminal Behavior
-
The Society for AIDS CareThe University of Hong KongCompleted
-
Medical University of ViennaRecruitingEchocardiography | Acute DyspneaAustria
-
Medical University of ViennaWithdrawnTelemedicine | EchocardiographyAustria
-
Mahidol UniversityUniversity of Puerto Rico; US Military HIV Research ProgramActive, not recruiting
-
Medical University of ViennaCompletedCardiopulmonary Resuscitation | Ultrasound | EchocardiographyAustria